Pathogenesis of asthma Inflammatory cells Structural cells Mediators Effects
Inflammatory cells - mast cells - eosinophils - Th2 cells - basophils - neutrophils - platelets Structural cells - epithelial cells - smooth mm cells - endothelial cells - fibroblasts - nerves
Mediators
Effects
Guideline goals for successful asthma management
Current control - control of symptoms - maintain normal activity levels - maintain pulmonary function Future risk - avoid adverse treatment effects - prevent asthma exacerbation - prevent asthma mortality
M3 receptor under stimulation by the agonist Ach mimics what effect?
Bronchoconstriction
Increased bronchial gland secretions
Increased mediator release
Beta 2 receptor under stimulation by the agonist NA mimics what effect?
Bronchodilatation
Mast cell stabilization
Increased mucocilliary clearance
Decreased microvascular permeability
Alpha 1, Alpha 2 receptor under stimulation by the agonist NA mimics what effect?
Bronchoconstriction
Decreased gland secretions
H1 receptor under stimulation by the agonist histamine mimics what effect?
Bronchoconstriction
Inflammatory reaction
5-HT3 receptor under stimulation by the agonist serotonin mimics what effect?
Bronchoconstriction
Beta 2 receptor under stimulation by the agonist bradykinin mimics what effect?
Bronchoconstriction
Pharmaceutical options for asthma treatment
Corticosteroids Leukotriene antagonists Mast cell stabilizers Anticholinergic drugs Theophylline Selective beta 2 adrenergic agonists
Which drug class of asthma pharmacotherapy results in reduced bronchial hyper-reactivity?
Mast cell stabilizers
Which drug class of asthma pharmacotherapy results in decreased response to allergens?
Leukotriene antagonists
Which drug class of asthma pharmacotherapy results aids in prevention of progression of chronic asthma, rescue course in rapidly deteriorating conditions and IV for acute exacerbations?
Corticosteroids
Which drug class of asthma pharmacotherapy results in relief of acute exacerbation and control/prevention of chronic asthma?
Anticholinergic drugs
Theophylline
Selective beta 2 adrenergic agonists
Definition of severe asthma
Asthma that requires treatment w/ high dose inhaled corticosteroids + a second controller and/or systemic corticosteroids to prevent it from becoming uncontrolled or that remains uncontrolled despite this therapy
To qualify:
Asthma diagnosis should be confirmed
Comorbidities should be address
Definition of uncontrolled asthma
At least 1 of the following
What should you check for in uncontrolled asthma before changing the treatment?
Incorrect diagnosis Significant comorbidities Poor compliance Poor inhaler technique Environmental factors (allergen exposure, occupation, smoking)
Management of refractory asthma
Life-threatening
Most commonly precipitated by URTIs
Hydrocortisone 100 – 200 mg 4 – 8hourly infusion
Nebulised salbutamol 2.5 – 5mg with ipratropium bromide 0.5 mg driven by O2
High flow humidified O2
Intubation & mechanical ventilation prn
Antibiotic treatment of respiratory tract infection
Correct dehydrationand acidosis
Saline + sodium bicarbonate infusion
Inhaled + local corticosteroid options
Beclometasone (Beclate)
Budesonide (Pulmicort)
Ciclesonide (Alvesco)
Fluticasone (Flixotide)
Systemic (oral/IV) corticosteroid options
Prednisone (Meticorten) Methylprednisolone (Medrol) Betamethasone (Celestone) Dexamethasone (Decasone) Hydrocortisone (Solucortef) Triamcinolone (Kenalog)
Indication for corticosteroid use in asthma treatment?
Most effective controller therapy available for asthma
ICS not systemic (severe S/E)
Mechanism of action of corticosteroids in asthma treatment
What is the pathophysiology of cysteinyl leukotrienes in asthma?
Constriction of bronchiolar smooth muscle Airway hyperresponsiveness Plasma exudation Eosinophilic inflammation Increased endothelial permeability Promotion of mucous secretion
Mechanism of action of anti-leukotrienes in asthma treatment?
Selective reversible inhibitors of cysteinyl
leukotrine-1 receptor, thus blocking the effects of cysteinyl leukotrines (LTC4, LTD4, LTE4) (Montelukast, Zafirlukast)
Inhibitor of 5-lipoxygenase pathway (Zileuton)
Anti-leukotriene options for asthma treatment?
Montelukast (Singulair)
Zafirlukast (Accolate)
Zileuton (not available in SA)